Publisher: Icon Group International, Inc.
Category: Drug Discovery

Drug Discovery market research reports by Icon Group International, Inc.

(361 reports matching your criteria)
    • The 2025-2030 World Outlook for Gout Therapeutics

      The 2025-2030 World Outlook for Gout Therapeutics This study covers the world outlook for gout therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Breakthrough Therapy Designation

      The 2025-2030 World Outlook for Breakthrough Therapy Designation This study covers the world outlook for breakthrough therapy designation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Inhalation and Nasal Spray Drugs

      The 2025-2030 World Outlook for Inhalation and Nasal Spray Drugs This study covers the world outlook for inhalation and nasal spray drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Hepatitis C Therapeutics

      The 2025-2030 World Outlook for Hepatitis C Therapeutics This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Hepatitis B Therapeutics

      The 2025-2030 World Outlook for Hepatitis B Therapeutics This study covers the world outlook for hepatitis b therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Cancer Therapeutics

      The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Immunology Therapeutics

      The 2025-2030 World Outlook for Immunology Therapeutics This study covers the world outlook for immunology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Allergy Diagnostics and Therapeutics

      The 2025-2030 World Outlook for Allergy Diagnostics and Therapeutics This study covers the world outlook for allergy diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Sexually Transmitted Disease Therapeutics

      The 2025-2030 World Outlook for Sexually Transmitted Disease Therapeutics This study covers the world outlook for sexually transmitted disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Therapeutics for Optometry

      The 2025-2030 World Outlook for Therapeutics for Optometry This study covers the world outlook for therapeutics for optometry across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Pneumonia Therapeutics

      The 2025-2030 World Outlook for Pneumonia Therapeutics This study covers the world outlook for pneumonia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for NSCLC Therapeutics

      The 2025-2030 World Outlook for NSCLC Therapeutics This study covers the world outlook for NSCLC therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Polypill Products

      The 2025-2030 World Outlook for Polypill Products This study covers the world outlook for polypill products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Hydroxyurea Sickle Cell Disease Treatments

      The 2025-2030 World Outlook for Hydroxyurea Sickle Cell Disease Treatments This study covers the world outlook for hydroxyurea sickle cell disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Colorectal Cancers

      The 2025-2030 World Outlook for Colorectal Cancers This study covers the world outlook for colorectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Drug Discovery Technologies

      The 2025-2030 World Outlook for Drug Discovery Technologies This study covers the world outlook for drug discovery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Mental Disorder Drugs

      The 2025-2030 World Outlook for Mental Disorder Drugs This study covers the world outlook for mental disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Postoperative Pain Therapeutics

      The 2025-2030 World Outlook for Postoperative Pain Therapeutics This study covers the world outlook for postoperative pain therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Fragment Screening Drug Discovery

      The 2025-2030 World Outlook for Fragment Screening Drug Discovery This study covers the world outlook for fragment screening drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Albumin Plasma Protein Therapeutics

      The 2025-2030 World Outlook for Albumin Plasma Protein Therapeutics This study covers the world outlook for albumin plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Liver Disease Therapeutics

      The 2025-2030 World Outlook for Liver Disease Therapeutics This study covers the world outlook for liver disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Sepsis Drugs

      The 2025-2030 World Outlook for Sepsis Drugs This study covers the world outlook for sepsis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More

    • The 2025-2030 World Outlook for Marine Derived Drugs

      The 2025-2030 World Outlook for Marine Derived Drugs This study covers the world outlook for marine derived drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs

      The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Anti-Hepatitis Drugs and Vaccines

      The 2025-2030 World Outlook for Anti-Hepatitis Drugs and Vaccines This study covers the world outlook for anti-hepatitis drugs and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

3 4 5 6 7 8 9 10 11 12

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings